ARK Genomic Revolution ETF (ARKG) Holdings
ARKG holdings summary
as of Oct 23, 2026- Holdings
- 33 positions listed
- Top 10 weight
- 58.3% of net assets
- Effective holdings
- 21 equal-weight equivalent
- Largest holding
- TXG 8.83% 10x Genomics, Inc.
- Annual turnover
- 28.8% of the portfolio traded
All ARKG holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics, Inc. | Healthcare | 8.83% | $190.7M | $9.10B | — |
| 2 | TEM | Tempus AI, Inc. | Healthcare | 8.15% | $176.1M | $11.68B | — |
| 3 | TWST | Twist Bioscience Corporation | Healthcare | 7.80% | $168.4M | $8.80B | — |
| 4 | CRSP | CRISPR Therapeutics AG | Healthcare | 5.58% | $120.6M | $4.76B | — |
| 5 | NTRA | Natera, Inc. | Healthcare | 5.08% | $109.6M | $56.71B | — |
| 6 | ILMN | Illumina, Inc. | Healthcare | 5.03% | $108.7M | $39.64B | 49.0 |
| 7 | GH | Guardant Health, Inc. | Healthcare | 4.97% | $107.4M | $21.28B | — |
| 8 | ABSI | Absci Corporation | Healthcare | 4.63% | $99.9M | $1.42B | — |
| 9 | LLY | Eli Lilly and Company | Healthcare | 4.30% | $93.0M | $1.12T | 42.2 |
| 10 | CDNA | CareDx, Inc | Healthcare | 3.92% | $84.6M | $3.31B | 30.8 |
| 11 | BEAM | Beam Therapeutics Inc. | Healthcare | 3.45% | $74.5M | $2.42B | — |
| 12 | VCYT | Veracyte, Inc. | Healthcare | 3.32% | $71.6M | $3.47B | 30.8 |
| 13 | CMPS | COMPASS Pathways plc | Healthcare | 2.91% | $63.0M | $1.49B | — |
| 14 | NRIX | Nurix Therapeutics, Inc. | Healthcare | 2.76% | $59.6M | $2.67B | 10.0 |
| 15 | RXRX | Recursion Pharmaceuticals, Inc. | Healthcare | 2.65% | $57.1M | $1.86B | — |
| 16 | SDGR | Schrödinger, Inc. | Healthcare | 2.59% | $56.0M | $1.69B | — |
| 17 | ADPT | Adaptive Biotechnologies Corporation | Healthcare | 2.18% | $47.1M | $3.83B | — |
| 18 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 1.97% | $42.7M | $1.60B | — |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 1.96% | $42.2M | $7.14B | — |
| 20 | WGS | GeneDx Holdings Corp. | Healthcare | 1.82% | $39.4M | $1.90B | — |
| 21 | BFLY | Butterfly Network, Inc. | Healthcare | 1.74% | $37.5M | $1.93B | — |
| 22 | ALMR | Alamar Biosciences, Inc. | Healthcare | 1.61% | $34.8M | $1.75B | — |
| 23 | PRME | Prime Medicine, Inc. | Healthcare | 1.48% | $32.0M | $629.4M | — |
| 24 | ARCT | Arcturus Therapeutics Holdings Inc. | Healthcare | 1.46% | $31.4M | $293.9M | — |
| 25 | MASS | 908 Devices Inc. | Healthcare | 1.15% | $24.9M | $465.4M | — |
| 26 | FRNM | Freenome, Inc. | Healthcare | 1.08% | $23.3M | $1.26B | — |
| 27 | PSNL | Personalis, Inc. | Healthcare | 1.05% | $22.8M | $1.67B | — |
| 28 | PACB | Pacific Biosciences of California, Inc. | Healthcare | 1.04% | $22.4M | $537.7M | — |
| 29 | GENB | Generate Biomedicines, Inc. | Healthcare | 1.02% | $22.1M | $1.55B | — |
| 30 | SCTX | Scribe Therapeutics Inc. | Healthcare | 0.92% | $19.9M | $380.1M | — |
| 31 | CERS | Cerus Corporation | Healthcare | 0.84% | $18.2M | $439.3M | — |
| 32 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 0.55% | $11.8M | $8.62B | — |
| 33 | QSI | Quantum-Si incorporated | Healthcare | 0.40% | $8.6M | $245.1M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($2.16B). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
ARKG sector breakdown
Sum of the weights of the holdings in each sector.
ARKG top industries
ARKG overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| IWM | iShares Russell 2000 ETF | 2.0% | 24 of 1,962 | 0.19% |
| VTI | Vanguard Total Stock Market ETF | 1.6% | 30 of 2,941 | 0.03% |
| SPY | SPDR S&P 500 ETF | 1.5% | 2 of 502 | 0.09% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 1 of 8,035 | 0.05% |
| QQQ | Invesco QQQ ETF | 0.0% | 0 of 101 | 0.17% |
| DIA | SPDR Dow Jones Industrial Average ETF | 0.0% | 0 of 30 | 0.16% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the ARKG portfolio
ARK Genomic Revolution ETF holds 33 positions. The ten largest make up 58.3% of the fund, so it behaves like a portfolio of about 21 equally weighted stocks. The biggest positions are 10x Genomics, Inc. (8.83%), Tempus AI, Inc. (8.15%), Twist Bioscience Corporation (7.80%), CRISPR Therapeutics AG (5.58%), Natera, Inc. (5.08%).
By sector, Healthcare is 98.2%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 23, 2026; positions change as the fund rebalances.
Related: ARKG chart, ARKG performance, ARKG overview.
ARKG holdings FAQ
How many holdings does ARKG have?
ARKG holds 33 positions as of October 23, 2026.
What are the top 10 holdings of ARKG?
The ten largest holdings are 10x Genomics, Inc. (8.83%), Tempus AI, Inc. (8.15%), Twist Bioscience Corporation (7.80%), CRISPR Therapeutics AG (5.58%), Natera, Inc. (5.08%), Illumina, Inc. (5.03%), Guardant Health, Inc. (4.97%), Absci Corporation (4.63%), Eli Lilly and Company (4.30%), CareDx, Inc (3.92%). Together they are 58.3% of the fund.
What percentage of ARKG is 10x Genomics, Inc.?
10x Genomics, Inc. is the largest holding at 8.83% of net assets, about $190.7M of the fund's $2.16B.
How concentrated is ARKG?
The top 10 holdings are 58.3% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) ARKG behaves like a portfolio of about 21 equally weighted stocks.